Home › Interstitial Lung Diseases › New York › Queens
Interstitial Lung Diseases clinical trials in Queens, NY
3 studies for Interstitial Lung Diseases are looking for participants at sites in and around Queens (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
RecruitingPhase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi away
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingObservational study
- Northwell Health, New Hyde Park · 9 mi away
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
RecruitingPhase 3
- Northwell Health, New Hyde Park · 9 mi away
About Interstitial Lung Diseases
Interstitial lung diseases are a group of diseases that inflame or scar the lungs. Breathing in particles (asbestosis, silicosis) causes some types.
More about Interstitial Lung Diseases on MedlinePlus
Interstitial Lung Diseases trials in other cities
- New York City, NY18 studies
- Philadelphia, PA16 studies
- Los Angeles, CA14 studies
- Durham, NC13 studies
- Kansas City, KS13 studies
- Charleston, SC13 studies
- Chicago, IL12 studies
- Houston, TX12 studies
- Aurora, CO11 studies
- Ann Arbor, MI11 studies
- Phoenix, AZ9 studies
- Salt Lake City, UT9 studies
Other studies in Queens
- Breast Cancer63 studies
- Non-Small Cell Lung Cancer49 studies
- Colorectal Cancer31 studies
- Metastatic Cancer28 studies
- Ovarian Cancer28 studies
- Prostate Cancer27 studies
- Cancer (all types)26 studies
- Endometrial Cancer25 studies
- Lung Cancer22 studies
- Acute Myeloid Leukemia21 studies
- Head and Neck Squamous Cell Carcinoma20 studies
- Multiple Myeloma20 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.